Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey

Pediatric Hematology and Oncology

Volumn 23, Issue 3, 2006, Pages 217-229

  Tezcan, Gulsun ^a   Kupesiz, Alphan ^a   Ozturk, Feryal ^a   Ogunc, Dilara ^a   Gultekin, Meral ^a   Yesilipek, Akif ^a   Hazar, Volkan ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Cancer; Children; Febrile neutropenia

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CEFEPIME; CEFTAZIDIME; COTRIMOXAZOLE; VANCOMYCIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AMEBIASIS; ARTICLE; BACTEREMIA; BONE TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COAGULASE POSITIVE STAPHYLOCOCCUS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEMOGRAPHY; DEVICE INFECTION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE PREDISPOSITION; ENDOCARDITIS; ENTEROBACTER INFECTION; FEBRILE NEUTROPENIA; FEMALE; FEVER; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMATOLOGIC DISEASE; HERPES LABIALIS; HUMAN; HYPOTENSION; LOWER RESPIRATORY TRACT INFECTION; MALE; MEDICAL DOCUMENTATION; MEDICAL INFORMATION; MONOCYTOPENIA; MORTALITY; MOUTH INFECTION; NEUROBLASTOMA; NEUTROPENIA; NONHODGKIN LYMPHOMA; PNEUMONIA; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS; SKIN INFECTION; SOFT TISSUE SARCOMA; STAPHYLOCOCCUS INFECTION; SYMPTOMATOLOGY; TERTIARY HEALTH CARE; TREATMENT INDICATION; TREATMENT OUTCOME; TUBERCULOUS MENINGITIS; TURKEY (REPUBLIC); TYPHLITIS; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BACTERIAL INFECTIONS; CANDIDIASIS; CATHETERIZATION, CENTRAL VENOUS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; FEVER; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; HYPOTENSION; INFANT; MALE; NEOPLASMS; NEUTROPENIA; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TURKEY;

EID: 33644839437     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010500506719     Document Type: Article

References (24)

1. Rackoff WR, Gonin R, Robinson C, Kreissman SG, Breitfeld PB. Predicting the risk of bacteremia in children with fever and neutropenia. J Clin Oncol. 1996;14:919-924.
2. Roguin A, Kasis I, Ben-Arush M, Sharon R, Berant M. Fever and neuropenia in children with malignant disease. Pediatr Hematol Oncol. 1996;13:503-510.
3. Lucas KG, Brown AE, Armstrong D, Chapman D, Heller G. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complication of sepsis. Cancer. 1996;77:791-798.
4. Donovitz GR. Fever in compromised host. Infect Dis Clin North Am. 1996;10:129-148.
5. Gencer S, Salepci T, Ozer S. Evaluation of infectious etiology and prognostic risk factors of febrile episodes in neutropenic cancer patients. J Infect. 2003;47:65-72.
6. Huges WT, Armstrong D, Bodey GP, et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730-751.
7. Akova M. Etiology of bacterial infections in cancer patients in Europe: an ever changing scenerio (12th ECCMID, Milan, Italy, 21-24 April, Abstract no: S344). Clin Microbiol Infect. 2002;8(suppl 1):50.
8. Aquino VM, Pappo A, Buchanan GR, Tkaczewski I, Mustafa MM. The changing epidemiology of bacteremia in neutropenic children with cancer. Pediatr Infect Dis J. 1995;14:140-143.
9. Rolston KVI, Tarrand JJ. Pseudomonas aerugenosa - still a frequent pathogen in patients with cancer: 11-year experience at a comprehensive cancer center. Clin Infect Dis. 1999;29:463-464.
10. Huges WT, Armstrong D, Bodey GP, et al. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis. 1997;25:551-573.
11. Saez Llorenz X, McCracken GH. Sepsis syndrome and septic shock in pediatrics: current concepts of terminology, pathophysiology, and management. J Pediatr. 1993;123:497-508.
12. Mermel LA, Farr BM, Sherertz RJ. et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001;32:1249-1272.
13. Bodey GP, Buckley M, Sahte YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infections in patients with acute leukemia. Ann Intern Med. 1966;64:328-340.
14. Santolaya ME, Alvarez AM, Becker A, et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol. 2001;19:3415-3421.
15. Hann I, Viscoli C, Paesman M, et al. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from EORTC studies. Br J Haematol. 1997;99:580-588.
16. The EORTC International Antimicrobial Therapy Project Group. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J Infect Dis. 1978;137:14-29.
17. Cometta A, Calandra T, Gaya H, et al. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'adulto Infection Program. Antimicrob Agents Chemother. 1996;40:1108-1115.
18. Baorto EP, Aquino VM, Mullen CA, et al. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer. 2001;92:909-913.
19. Aquino VM, Pappo A, Buchanan GR, et al. The changing epidemiology of bacteremia in neutropenic children with cancer. Pediatr Infect Dis J. 1995;14:140-143.
20. Erman M, Akova M, Akan H, et al. Comparison of cefepime and ceftazidime in combination with amikacin in the emprical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter study. Scand J Infect Dis. 2001;33:827-831.
21. Haubt R, Romanengo M, Fears T, et al. Incidence of septicemias and invasive mycoses in children undergoing treatment for solid tumors: a 12-year experience at a single Italian institution. Eur J Cancer. 2001;37:2413-2419.
22. Talcott JA, Finberg R, Mayer RJ, Goldman L. The medical course of cancer patients with fever and neutropenia. Arch Intern Med. 1988;148:2561-2568.
23. Orudjev E, Lange BJ. Evolving concepts of management of febrile neutropenia in children with cancer. Med Pediar Oncol. 2002;39:77-85.
24. Jones GR, KOnsler GK, Dunaway RP, et al. Infection risk factors in febrile, neutropenic children and adolescents. Pediatr Hematol Oncol. 1996;13:217-229.